Physicians' Academy for Cardiovascular Education

Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides

Meeting report with presentation slides, videos and online CME of a PACE-CME symposium held during ESC 2020, The Digital Experience.

E-learning The evolving role of triglyceride-rich lipoproteins

EBAC-accredited E-Learning

Online-CME - This course consists of 3 parts.
This course consists of 3 parts.

This educational program consists of three presentations on residual CVD risk with a focus on triglycerides and triglyceride-rich lipoproteins.

Introduction: The evolving role of triglycerides

10' education - Nov. 15, 2020 - Prof. Peter LIbby, MD
Prof. Libby gives an introduction to the symposium about the evolving role of triglycerides in residual CV risk, that was held during the virtual ESC 2020 congress.

Prof. Libby gives an introduction to the symposium about the evolving role of triglycerides in residual CV risk, that was held during the virtual ESC 2020 congress.

Lessons from REDUCE-IT

10' education - Nov. 12, 2020 - Prof. Deepak Bhatt, MD
Prof. Bhatt gives a recap of the findings of the main REDUCE-IT trial with icosapent ethyl and of subsequent analyses.

Prof. Bhatt gives a recap of the findings of the main REDUCE-IT trial with icosapent ethyl and of subsequent analyses.

Non-LDL-c parameters in CV risk management and guidelines

10' education - Oct. 13, 2020 - Prof. Kausik Ray, MD
In patients with dyslipidemia, levels of apoB-containing lipoproteins are elevated, containing both triglycerides and cholesterol. What are treatment targets for these non-LDL-c parameters and how can these be achieved?

In patients with dyslipidemia, levels of apoB-containing lipoproteins are elevated, containing both triglycerides and cholesterol. What are the treatment targets of these non-LDL-c parameters and how can these be achieved?

The residual risk challenge in CVD: How important are triglycerides?

10' education - Sep. 25, 2020 - Prof. Ulf Landmesser, MD
What is the role of triglyceride-rich lipoproteins in residual risk in patients with ASCVD?

What is the role of triglyceride-rich lipoproteins in residual risk in patients with ASCVD?

Discussion: Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides

10' education - Sep. 23, 2020

Expert discussion on novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides.

Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides